VVM
Versant Venture Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.2M | Hold |
498,558
| – | – | 29.52% | 2 |
|
|
2025
Q1 | $17M | Hold |
498,558
| – | – | 28.18% | 2 |
|
|
2024
Q4 | $19.6M | Hold |
498,558
| – | – | 22.62% | 2 |
|
|
2024
Q3 | $23.4M | Hold |
498,558
| – | – | 36.84% | 1 |
|
|
2024
Q2 | $26.9M | Hold |
498,558
| – | – | 34.84% | 1 |
|
|
2024
Q1 | $34M | Hold |
498,558
| – | – | 32.95% | 1 |
|
|
2023
Q4 | $31.2M | Hold |
498,558
| – | – | 8.03% | 2 |
|
|
2023
Q3 | $22.6M | Hold |
498,558
| – | – | 12.03% | 3 |
|
|
2023
Q2 | $28M | Hold |
498,558
| – | – | 33.2% | 2 |
|
|
2023
Q1 | $22.5M | Hold |
498,558
| – | – | 47.01% | 1 |
|
|
2022
Q4 | $20.3M | Hold |
498,558
| – | – | 41.93% | 1 |
|
|
2022
Q3 | $32.6M | Hold |
498,558
| – | – | 55.55% | 1 |
|
|
2022
Q2 | $30.3M | Hold |
498,558
| – | – | 46.45% | 1 |
|
|
2022
Q1 | $31.3M | Hold |
498,558
| – | – | 31.24% | 1 |
|
|
2021
Q4 | $37.8M | Hold |
498,558
| – | – | 20.21% | 2 |
|
|
2021
Q3 | $55.8M | Sell |
498,558
-10,000
| -2% | -$1.12M | 23.11% | 1 |
|
|
2021
Q2 | $82.3M | Sell |
508,558
-1,046,402
| -67% | -$169M | 27.28% | 1 |
|
|
2021
Q1 | $189M | Sell |
1,554,960
-1,485,502
| -49% | -$181M | 36.92% | 1 |
|
|
2020
Q4 | $466M | Sell |
3,040,462
-591,194
| -16% | -$90.5M | 48.34% | 1 |
|
|
2020
Q3 | $304M | Sell |
3,631,656
-551,408
| -13% | -$46.1M | 55.59% | 1 |
|
|
2020
Q2 | $307M | Sell |
4,183,064
-22,551
| -0.5% | -$1.66M | 44.16% | 1 |
|
|
2020
Q1 | $177M | Hold |
4,205,615
| – | – | 48.6% | 1 |
|
|
2019
Q4 | $256M | Sell |
4,205,615
-28,255
| -0.7% | -$1.72M | 77.19% | 1 |
|
|
2019
Q3 | $174M | Sell |
4,233,870
-15,018
| -0.4% | -$616K | 67.15% | 1 |
|
|
2019
Q2 | $200M | Hold |
4,248,888
| – | – | 58.31% | 1 |
|
|
2019
Q1 | $152M | Buy |
4,248,888
+640,014
| +18% | +$22.9M | 50% | 1 |
|
|
2018
Q4 | $103M | Hold |
3,608,874
| – | – | 51.04% | 1 |
|
|
2018
Q3 | $160M | Hold |
3,608,874
| – | – | 54.44% | 1 |
|
|
2018
Q2 | $212M | Sell |
3,608,874
-997,368
| -22% | -$58.6M | 66.16% | 1 |
|
|
2018
Q1 | $211M | Buy |
+4,606,242
| New | +$211M | 67.34% | 1 |
|